Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Merck & Co. 16.286, CSL 3.6525.
* CSL reports semi-annually. Values are evenly split across both quarters within each half.
Merck & Co. vs CSL Net Worth and Market Cap
Merck & Co. (MRK) and CSL (CSL.AX) are peers in Vaccines. Merck & Co. reported revenue of $16.3B as of Q1 2026, compared with $7.3B for CSL. Merck & Co. leads on revenue.
Merck & Co.'s gross margin is 81.9% versus 44.4% for CSL. Merck & Co.'s net margin is -26.0% versus -40.2% for CSL.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Merck & Co., CSL.| Metric | Merck & Co. | CSL |
|---|---|---|
| Market Cap | - | - |
| Revenue | $16.29B | $7.30B |
| Cost of Revenue | $2.94B | $4.06B |
| Gross Profit | $13.34B | $3.24B |
| Operating Income | $-1.88B | $1.39B |
| Net Income | $-4.24B | $-2.94B |
| R&D Expense | $12.56B | $614.00M |
| Earnings Per Share | -$1.72 | -$6.14 |
| Gross Margin | 81.9% | 44.4% |
| Operating Margin | -11.6% | 19.0% |
| Net Profit Margin | -26.0% | -40.2% |
| Free Cash Flow | $2.93B | $1.76B |
| Cumulative Free Cash Flow | $245.22B | $21.56B |
| Operating Cash Flow | $3.92B | $2.09B |
| Cash & Equivalents | $5.33B | $1.51B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.